Abstract
Alpha-fetoprotein (AFP) for long was known as immunomodulator and tumor marker having multifaceted actions on the activity of normal and transformed cells. In present study, we have investigated the involvement of AFP in regulation of THP-1 cell line invasion and underlying mechanisms. Treatment with human recombinant AFP causes up-regulation of MMP9 expression, chemotaxis and calcium mobilization, and increases invasion through Matrigel, with no significant impact on THP-1 cell growth or viability. Using small molecule inhibitors, we have shown that the rhAFP-induced MMP9 expression depends on the activation of ERK1,2, JNK and Akt kinases, with the involvement of NFκB and likely, AP-1 transcription factors. In contrast, inhibition of p38 kinase, but not of JNK, had dramatic suppressive effect on the rhAFP-triggered chemotaxis. In addition, rhAFP-induced MMP9 expression and calcium response were completely blocked by pertussis toxin, indicating that Gi-protein-coupled receptor(s) has a mediatory role in these processes. CCR5 chemokine receptor is the only known Gi-protein binding to AFP. The action of CCR5 inhibitor Maraviroc results in partial suppression of MMP9 up-regulation and calcium response suggesting that CCR5 might be involved in these effects.
Similar content being viewed by others
Change history
20 February 2023
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1007/s11010-023-04675-6
References
Mizejewski GJ (2004) Biological roles of alpha-fetoprotein during pregnancy and perinatal development. Exp Biol Med (Maywood) 229:439–463
Mizejewski GJ (2011) Therapeutic use of human alpha-fetoprotein in clinical patients: is a cancer risk involved? Int J Cancer 128:239–242. doi:10.1002/ijc.25292
Jacobson HI, Bennett JA, Mizejewski GJ (1990) Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol. Cancer Res 50:415–420
Arora N, Madhusudhana S (2011) Spontaneous regression of hepatocellular cancer: case report and review of literature. Gastrointest Cancer Res 4:141–143
Dudich E, Semenkova L, Dudich I, Denesyuk A, Tatulov E, Korpela T (2006) Alpha-fetoprotein antagonizes X-linked inhibitor of apoptosis protein anticaspase activity and disrupts XIAP-caspase interaction. FEBS J 273:3837–3849. doi:10.1111/j.1742-4658.2006.05391.x
Li P, Wang SS, Liu H, Li N, McNutt MA, Li G, Ding HG (2011) Elevated serum alpha fetoprotein levels promote pathological progression of hepatocellular carcinoma. World J Gastroenterol 17:4563–4571. doi:10.3748/wjg.v17.i41.4563
Ishigami S, Natsugoe S, Nakashima H, Tokuda K, Nakajo A, Okumura H, Matsumoto M, Nakashima S, Hokita S, Aikou T (2006) Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer. Hepatogastroenterology 53:338–341
Li M, Li H, Li C, Wang S, Jiang W, Liu Z, Zhou S, Liu X, McNutt MA, Li G (2011) Alpha-fetoprotein: a new member of intracellular signal molecules in regulation of the PI3 K/AKT signaling in human hepatoma cell lines. Int J Cancer 128:524–532. doi:10.1002/ijc.25373
Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC (2004) High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer 112:44–50. doi:10.1002/ijc.20279
Takahashi Y, Ohta T, Mai M (2004) Angiogenesis of AFP producing gastric carcinoma: correlation with frequent liver metastasis and its inhibition by anti-AFP antibody. Oncol Rep 11:809–813
Dudich E, Dudich I, Semenkova L, Benevolensky S, Morozkina E, Marchenko A, Zatcepin S, Dudich D, Soboleva G, Khromikh L, Roslovtceva O, Tatulov E (2012) Engineering of the Saccharomyces cerevisiae yeast strain with multiple chromosome-integrated genes of human alpha-fetoprotein and its high-yield secretory production, purification, structural and functional characterization. Protein Expr Purif 84:94–107. doi:10.1016/j.pep.2012.04.008
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Lopatina T, kalinina N, Karagyaur M, Stambolsky D, Rubina K, Revischin A, Pavlova G, Parfyonova Y, Tkachuk V (2011) Adipose-derived stem cells stimulate regeneration of peripheral nerves: BDNF secreted by these cells promotes nerve healing and axon growth de novo. PLoS One. doi:10.1371/journal.pone.0017899
Menshikov M, Torosyan N, Elizarova E, Plakida K, Vorotnikov A, Parfyonova Y, Stepanova V, Bobik A, Berk B, Tkachuk V (2006) Urokinase induces matrix metalloproteinase-9/gelatinase B expression in THP-1 monocytes via ERK1/2 and cytosolic phospholipase A2 activation and eicosanoid production. J Vasc Res 43:482–490. doi:10.1159/000095248
Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+indicators with greatly improved fluorescence properties. J Biol Chem 260:3440–3450
Bjorklund M, Koivunen E (2005) Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755:37–69. doi:10.1016/j.bbcan.2005.03.001
Mook OR, Frederiks WM, Van Noorden CJ (2004) The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705:69–89. doi:10.1016/j.bbcan.2004.09.006
Potapovich AI, Pastore S, Kostyuk VA, Lulli D, Mariani V, De Luca C, Dudich EI, Korkina LG (2009) Alpha-fetoprotein as a modulator of the pro-inflammatory response of human keratinocytes. Br J Pharmacol 158:1236–1247. doi:10.1111/j.1476-5381.2009.00401.x
Liang OD, Korff T, Eckhardt J, Rifaat J, Baal N, Herr F, Preissner KT, Zygmunt M (2004) Oncodevelopmental alpha-fetoprotein acts as a selective proangiogenic factor on endothelial cell from the fetomaternal unit. J Clin Endocrinol Metab 89:1415–1422
Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, Rao A (1997) IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278:860–866
Mizejewski GJ (2011) Review of the putative cell-surface receptors for alpha-fetoprotein: identification of a candidate receptor protein family. Tumour Biol 32:241–258. doi:10.1007/s13277-010-0134-5
Li MS, Li PF, He SP, Du GG, Li G (2002) The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line. World J Gastroenterol 8:469–475
Moro R, Tamaoki T, Wegmann TG, Longenecker BM, Laderoute MP (1993) Monoclonal antibodies directed against a widespread oncofetal antigen: the alpha-fetoprotein receptor. Tumour Biol 14:116–130
Olson TS, Ley K (2002) Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol 283:R7–R28. doi:10.1152/ajpregu.00738.2001
Atemezem A, Mbemba E, Marfaing R, Vaysse J, Pontet M, Saffar L, Charnaux N, Gattegno L (2002) Human alpha-fetoprotein binds to primary macrophages. Biochem Biophys Res Commun 296:507–514
Lisi L, Tramutola A, De Luca A, Navarra P, Dello Russo C (2012) Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120. J Neurochem 120:106–114. doi:10.1111/j.1471-4159.2011.07549.x
Oppermann M, Mack M, Proudfoot AE, Olbrich H (1999) Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J Biol Chem 274:8875–8885
Gouwy M, Struyf S, Berghmans N, Vanormelingen C, Schols D, Van Damme J (2011) CXCR4 and CCR5 ligands cooperate in monocyte and lymphocyte migration and in inhibition of dual-tropic (R5/X4) HIV-1 infection. Eur J Immunol 41:963–973. doi:10.1002/eji.201041178
Tanaka T, Bai Z, Srinoulprasert Y, Yang BG, Hayasaka H, Miyasaka M (2005) Chemokines in tumor progression and metastasis. Cancer Sci 96:317–322. doi:10.1111/j.1349-7006.2005.00059.x
Mizejewski GJ (2002) Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy. Expert Rev Anticancer Ther 2:709–735. doi:10.1586/14737140.2.6.709
Pollard LC, Murray J, Moody M, Stewart EJ, Choy EH (2007) A randomised, double-blind, placebo-controlled trial of a recombinant version of human alpha-fetoprotein (MM-093) in patients with active rheumatoid arthritis. Ann Rheum Dis 66:687–689. doi:10.1136/ard.2006.059436
Suzuki Y, Zeng CQ, Alpert E (1992) Isolation and partial characterization of a specific alpha-fetoprotein receptor on human monocytes. J Clin Invest 90:1530–1536. doi:10.1172/JCI116021
Torres JM, Darracq N, Uriel J (1992) Membrane proteins from lymphoblastoid cells showing cross-affinity for alpha-fetoprotein and albumin. Isolation and characterization. Biochim Biophys Acta 1159:60–66
Seddiki N, Rabehi L, Benjouad A, Saffar L, Ferriere F, Gluckman JC, Gattegno L (1997) Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes. Glycobiology 7:1229–1236
Mira E, Lacalle RA, Gonzalez MA, Gomez-Mouton C, Abad JL, Bernad A, Martinez AC, Manes S (2001) A role for chemokine receptor transactivation in growth factor signaling. EMBO Rep 2:151–156. doi:10.1093/embo-reports/kve027
Fitzgerald ML, Moore KJ, Freeman MW, Reed GL (2000) Lipopolysaccharide induces scavenger receptor A expression in mouse macrophages: a divergent response relative to human THP-1 monocyte/macrophages. J Immunol 164:2692–2700
Gough PJ, Gordon S (2000) The role of scavenger receptors in the innate immune system. Microbes Infect 2:305–311
Post SR, Gass C, Rice S, Nikolic D, Crump H, Post GR (2002) Class A scavenger receptors mediate cell adhesion via activation of G(i/o) and formation of focal adhesion complexes. J Lipid Res 43:1829–1836
Gialeli C, Theocharis AD, Karamanos NK (2011) Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 278:16–27. doi:10.1111/j.1742-4658.2010.07919.x
Annabi B, Currie JC, Moghrabi A, Beliveau R (2007) Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg. Leuk Res 31:1277–1284. doi:10.1016/j.leukres.2006.10.001
Gaurnier-Hausser A, Rothman VL, Dimitrov S, Tuszynski GP (2008) The novel angiogenic inhibitor, angiocidin, induces differentiation of monocytes to macrophages. Cancer Res 68:5905–5914. doi:10.1158/0008-5472.CAN-07-6179
Solinas G, Germano G, Mantovani A, Allavena P (2009) Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 86:1065–1073. doi:10.1189/jlb.0609385
Dudich E, Semenkova L, Gorbatova E, Dudich I, Khromykh L, Tatulov E, Grechko G, Sukhikh G (1998) Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells. Tumour Biol 19:30–40
Sowa ME, Bennett EJ, Gygi SP, Harper JW (2009) Defining the human deubiquitinating enzyme interaction landscape. Cell 138:389–403. doi:10.1016/j.cell.2009.04.042
Acknowledgments
This work was supported by International Scientific and Technical Center (project #3808) and by Russian Foundation of Basic Research (projects #09-04-01664, 11-04-01850 and 12-04-00989). We thank Tatyana Bushueva and Yury Romanov for helping in performing experiments and preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Zubkova, E., Semenkova, L., Dudich, E. et al. RETRACTED ARTICLE: Alpha-fetoprotein contributes to THP-1 cell invasion and chemotaxis via protein kinase and Gi-protein-dependent pathways. Mol Cell Biochem 379, 283–293 (2013). https://doi.org/10.1007/s11010-013-1650-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-013-1650-6